Relative vs. absolute measures of benefit and risk: What's the difference?

Acta Psychiatrica Scandinavica

Volumn 121, Issue 2, 2010, Pages 94-102

  Citrome, L ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Absolute risk increase; Evidence based medicine; Hazard ratio; Number needed to harm; Number needed to treat; Odds ratio; Relative risk increase; Relative risk ratio

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MEDICAL DECISION MAKING; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REMISSION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; TREATMENT RESPONSE;

DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; RISK ASSESSMENT;

EID: 73549118356     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01449.x     Document Type: Review

References (23)

1. Citrome L. Compelling or irrelevant? Using number needed to treat can help decide. Acta Psychiatr Scand 2008 117 : 412 419.
2. Djoussé L, Gaziano JM, Buring JE, Lee IM. Egg consumption and risk of type 2 diabetes in men and women. Diabetes Care 2009 32 : 295 300.
3. Reaven GM, Lieberman JA, Sethuraman G et al. In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. J Psychiatr Res. 2009 43 : 997 1002.
4. Citrome L, Holt RIG. Eggs, diabetes, and risk: letter in response to Djoussé L, et al. Egg consumption and risk of type 2 diabetes in men and women. Diabetes Care. 2009 32 : e73.
5. Sackett DL, Rosenberg WMC, Gray JAM et al. Evidence based medicine: what it is and what it isn't. BMJ 1996 312 : 71 72.
6. Citrome L, Ketter TA. Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions. Int J Clin Pract 2009 63 : 353 359.
7. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2005 59 : 990 996.
8. Citrome L, Kantrowitz J. Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks. Expert Rev Neurother 2008 8 : 1079 1091.
9. Braithwaite W, Cole P, Feinstein AR et al. The role of epidemiology in decision-making. The Annapolis Center. 1999. Available at: http://www. annapoliscenter.org. Accessed 6 January 2009.
10. Hsu JL, Banerjee D, Kuschner WG. Understanding and identifying bias and confounding in the medical literature. South Med J 2008 101 : 1240 1245.
11. Citrome L. Show me the evidence: now what do I do with it? South Med J 2008 101 : 1197.
12. Kraemer HC. Reconsidering the odds ratio as a measure of 2 × 2 association in a population. Stat Med 2004 23 : 257 270.
13. Sackett DL. Down with odds ratios! Evidence-Based Medicine 1996 1 : 164 166.
14. Citrome L. Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications. Curr Drug Saf 2009 Sep 1. [Epub ahead of print].
15. Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence-based medicine: how to practice and teach EBM, 3rd edn. Edinburgh : Elsevier Churchill Livingstone, 2005.
16. Bristol-Myers-Squibb, Otsuka America Pharmaceutical Inc., Abilify. Available at: http://packageinserts.bms.com/pi/pi-abilify.pdf. Accessed 4 February 2009, 2008.
17. Berman RM, Marcus RN, Swanink R et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2007 68 : 843 853.
18. Marcus RN, McQuade RD, Carson WH et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2008 28 : 156 165.
19. Bauer M, Pretorius HW, Constant EL et al. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. J Clin Psychiatry 2009 70 : 540 549.
20. Citrome LL. The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents. Drugs Today (Barc) 2004 40 : 445 464.
21. Citrome LL, Holt RI, Zachry WM et al. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics. Ann Pharmacother 2007 41 : 1593 1603.
22. Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 2004 161 : 1709 1711.
23. Streiner DL, Cairney J. What's under the ROC? An introduction to receiver operating characteristics curves. Can J Psychiatry 2007 52 : 121 128.